|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





,1
* Molecular Biotechnology Program,
Department of Biochemistry and Center for Protein Science and Crystallography,
Department of Microbiology, and
Department of Anatomy, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;
|| Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Pediatrics, Department of Biological Chemistry and Molecular Pharmacology, and
¶ Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and
# Midwest Center for Structural Genomics and Structural Biology Center, Biosciences, Argonne National Laboratory, Argonne, Illinois, USA
1 Correspondence: Department of Biochemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. E-mail: pcshaw{at}cuhk.edu.hk
The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397–401, 429–437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73–91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.—Ng, A. K.-L., Zhang, H., Tan, K., Li, Z., Liu, J.-h., Chan, P. K.-S., Li, S.-M., Chan, W.-Y., Au, S. W.-N., Joachimiak, A., Walz, T., Wang, J.-H., Shaw, P.-C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.
Key Words: protein-RNA interaction crystal structure trimerization
This article has been cited by other articles:
![]() |
N. L. Varich, K. S. Kochergin-Nikitsky, E. V. Usachev, O. V. Usacheva, A. G. Prilipov, R. G. Webster, and N. V. Kaverin Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule J. Gen. Virol., July 1, 2009; 90(7): 1730 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Noton, M. Simpson-Holley, E. Medcalf, H. M. Wise, E. C. Hutchinson, J. W. McCauley, and P. Digard Studies of an Influenza A Virus Temperature-Sensitive Mutant Identify a Late Role for NP in the Formation of Infectious Virions J. Virol., January 15, 2009; 83(2): 562 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Hutchinson, M. D. Curran, E. K. Read, J. R. Gog, and P. Digard Mutational Analysis of cis-Acting RNA Signals in Segment 7 of Influenza A Virus J. Virol., December 1, 2008; 82(23): 11869 - 11879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |